Hormone Replacement Therapy: Updates and Fracture Data | Bone Biopsy: Clinical Indications, Limitations
Includes a Live Web Event on 04/11/2026 at 4:00 PM (EDT)
Hormone Replacement Therapy: Updates and Fracture Data
Sherri-Ann Burnett-Bowie, MD, MPH
Saturday, April 11, 2026, 4:00pm to 4:30pm Eastern Time (NY/USA)
Bone Biopsy: Clinical Indications, Limitations
Charles Ginsberg, MD, MAS
Saturday, April 11, 2026, 4:30pm to 5:00pm Eastern Time (NY/USA)
Description
This session will evaluate the role of bone biopsy in the management of metabolic bone disease. It will focus on how biopsy is done, what information it provides, and how it can be implemented in the management of bone disease. The talk will explore important areas of bone management like management in patients with kidney disease, abnormalities of bone turnover and patients who have failed therapies.
Objectives
- Discuss indications for bone biopsy in patients with CKD and bone disease
- Discuss the procedure and risks/benefits
- Work through a few cases in which biopsy may have changed therapy
Sherri-Ann Burnett-Bowie, MD, MPH
Physician, Associate Professor of Medicine
Massachusetts General Hospital, Harvard Medical School
Sherri-Ann M. Burnett-Bowie MD, MPH is an Associate Professor of Medicine at Harvard Medical School and a clinical investigator in the Massachusetts General Hospital Endocrine Unit, where her research focuses on the epidemiology of menopause and clinical trials of treatments for osteoporosis. She cares for patients seen at the Mass General Endocrine Associates and the Mass General Bone Density Center. Dr. Burnett-Bowie has received multiple awards to support her clinical investigation in mineral physiology and osteoporosis, and to acknowledge excellence in teaching, the promotion of diversity and inclusion, and mentoring.
Charles Ginsberg, MD, MAS
Associate Professor
UCSD, Division of Nephrology-Hypertension
Dr. Ginsberg is an Associate Professor in the Division of Nephrology-Hypertension at UCSD. His work focuses on bone health in persons with kidney disease as well as clinical trials in diabetic kidney disease. He has multiple NIH and foundation funded studies and is the director of the bone biopsy and histomorphometry program at UCSD. He is also the medical director of a home dialysis clinic.